🔬
Foundation Sciences · Genetics
Genomic Imprinting
Genomic imprinting is the parent-of-origin-specific epigenetic silencing of genes; both copies are present but only one is expressed.
📌 Learning Objectives
- Describe the underlying mechanism of Genomic Imprinting.
- Identify the key clinical features and complications of Genomic Imprinting.
- Outline the appropriate investigations and management of Genomic Imprinting.
- Discuss the implications for patients and families of Genomic Imprinting.
📋 Overview
Imprinting is established in gametogenesis through DNA methylation. Disorders include Prader–Willi, Angelman, Beckwith–Wiedemann and Silver–Russell syndromes.
🔬 Basic Science
Imprinting is established in gametogenesis through DNA methylation. Disorders include Prader–Willi, Angelman, Beckwith–Wiedemann and Silver–Russell syndromes.
🏥 Clinical Relevance
Methylation-specific testing is critical for diagnosis of imprinting disorders.
🧪 Investigations
Investigation depends on clinical context: relevant blood tests, imaging, and specific genetic or histopathological tests as appropriate. Refer to specialist services where indicated.
💊 Management
Management is condition-specific and typically multidisciplinary, combining medical therapy, surgical intervention where appropriate, supportive care, and family/genetic counselling.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
Common SBA themes: recognising the underlying mechanism, identifying classic clinical features, and choosing the first-line investigation or management step. Watch for inheritance pattern and characteristic associations.
imprinting
upd
methylation
beckwith-wiedemann
silver-russell
- Imprinting silences gene expression in a parent-of-origin-specific manner.
- Prader–Willi: loss of paternal contribution at 15q11–13.
- Angelman: loss of maternal contribution at 15q11–13.
- Beckwith–Wiedemann is an overgrowth syndrome from imprinting defects at 11p15.5.
- Methylation-specific MLPA is a key diagnostic tool.
Exam Pearls ⌄
⭐ High Yield
Imprinting silences gene expression in a parent-of-origin-specific manner.
Prader–Willi: loss of paternal contribution at 15q11–13.
Angelman: loss of maternal contribution at 15q11–13.
Beckwith–Wiedemann is an overgrowth syndrome from imprinting defects at 11p15.5.
Methylation-specific MLPA is a key diagnostic tool.
💡 Clinical Pearl
Imprinting: Methylation-specific testing is critical for diagnosis of imprinting disorders.
⚠️ Exam Tip — Common Mistakes
Confusing the mechanism of Genomic Imprinting with related conditions.
Missing classic clinical features of Genomic Imprinting in SBA stems.
Failing to consider Genomic Imprinting in the differential diagnosis.
Key Facts ⌄
Imprinting silences gene expression in a parent-of-origin-specific manner.
Prader–Willi: loss of paternal contribution at 15q11–13.
Angelman: loss of maternal contribution at 15q11–13.
Beckwith–Wiedemann is an overgrowth syndrome from imprinting defects at 11p15.5.
Methylation-specific MLPA is a key diagnostic tool.
Related Topics ⌄
References ⌄
- GMC MLA Content Map
- NICE Clinical Knowledge Summaries
- BMJ Best Practice
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →